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Abstract
In 'The normalization of 'sensible' recreational drug use' Parker, Williams and 
Aldridge (2002) present data on illegal drug use by adolescents and young adults 
in the UK. They argue that it is both widespread and largely socially benign - ie, 
normal. We contrast this 'normalisation' thesis with evidence of an increase in the 
introduction of drug policies - and drug testing - in British organisations. Such 
policies construct employee drug use as excessive enough to necessitate 
heightened management vigilance over workers, in order to preserve corporate 
interests. These contrasting representations of drug use inspire our discussion. 
We deploy the normal/ excessive couplet to unpick drug taking, to examine 
organisational drug policies and to comment upon emerging and potential 
resistance to these policies. Our contribution is to suggest that each of these 
activities can be understood as simultaneously normal and excessive, in an area 
where orthodox and critical analyses alike tend to be far more dualistic.  
Introduction
A central mode of analysis for Critical 
Management Studies scholars has been to 
critique the exercise of power in 
organisations through processes of 
normalisation. It is commonly argued in such 
work that modern organisations are 
characterised by a shift from traditional forms 
of management, where employees' behaviour 
is subject to direct surveillance, towards 
more diffuse systems of bureaucratic and 
latterly values-based control. The focus for 
such control is the cultivation of a sustained 
propensity amongst workers to follow 
management-sanctioned norms for 
organisational behaviour, such that 
'appropriate' workplace conduct becomes 
normal, inevitable, unthinking:
'It is the indirect path to the 
intensification of work, through the 
mechanism of rewarding behaviour 
relevant to the control system, rather 
than simply rewarding work itself, that 
imposes the new behaviour 
requirements on workers … 
Employers seek out and reward 
workers with the right behaviour 
traits.' (Edwards, 1979: 148-149)
Building on arguments like Edwards', other 
commentators have drawn upon the work of 
Michel Foucault to investigate further the 
ways in which contemporary management 
technologies aim to govern employee 
subjectivity through normalisation (see, for 
example, Knights and Willmott, 1989; du Gay 
and Salaman, 1992; Deetz, 1998).
Here we use the concept of normalisation to 
examine one specific managerial technology 
of control; workforce drug testing.1   In what 
is perhaps the most extensive analysis of 
such testing to date, Gilliom (1994) employs 
both Edwards' notion of bureaucratic control 
and Foucault's concept of the disciplinary 
society to argue that it may represent the 
zenith of management through normalisation. 
Taking samples of employees' urine, hair, 
blood, saliva or sweat to test for traces of 
previous drug consumption represents, for 
Gilliom, a round-the-clock and virtually 
inescapable system of biological surveillance 
that has little to do with actual intoxication or 
behaviour at work and much more with 
constructing normalised and obedient subject 
positions - and identifying those who 
transgress them.  
1 Unless otherwise stated, the term ‘drugs’ is used 
in this paper to refer to the ‘illicit’ use of controlled 
substances such as cannabis or cocaine, not 
medically prescribed ingestion or the 
consumption of alcohol, tobacco or caffeine.
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The context for Gilliom's critique is the US, 
where workforce drug testing is widespread: 
indeed we could argue that it is normal. The 
Independent Inquiry into Drug Testing at Work 
([IIDTW] 2004), for instance, suggests that 
between 40% and 50% of American 
organisations drug test their employees, 
meaning some 15 million US workers are 
tested each year. The paper at hand, 
however, deals with the UK, for several very 
specific reasons. First, and notwithstanding 
calls for such endeavours from Francis, 
Hanley and Wray (2003) and the IIDTW 
(2004), research into the topic of UK 
workforce drug testing is still relatively rare. 
Second, testing is not yet normal management 
practice in the UK - but there are indications 
that it may be on a similar trajectory to the US. 
In August 2004, for example, British Airways 
secured considerable media attention - with 
no obvious attendant opprobrium - by 
announcing that it was introducing drug and 
alcohol testing for all UK staff on a for cause 
basis.2   Previously only pilots had been 
subject to such a regime. Random testing is 
also now in place for those in the first six 
months of employment with the carrier. BA 
management say their decision is related to 
safety issues, and all three BA unions agreed 
the move - unusual in an organisation where 
industrial relations have been highly 
confrontational for some years now. And BA 
is not unique: the IIDTW (2004) suggest that 
around 4% of UK businesses tested staff at 
the time of their data gathering, with a further 
9% likely to introduce testing in the near 
future. Additionally 78% of employers 
surveyed reported that they would consider 
testing if they thought productivity was at 
stake. Guerrier (2003), similarly, cites an 
Observer article which notes that testing for 
drugs and alcohol is spreading from 'safety-
critical' to so-called 'business-critical' jobs in 
the UK (also see Francis et al., 2003; Warren 
& Wray-Bliss, 2003). So, although drug 
testing at work is still limited in the UK, a 
groundswell is building which suggests it is 
gradually becoming regarded as a legitimate 
managerial intervention. Accompanying and 
2 Undertaken where there is reason to believe that 
staff are working ‘under the influence’.
fuelling such momentum are constructions of 
drug user as necessarily sick and/ or 
dangerous. Here drug-taking employees are 
linked, with little or no supporting evidence, 
with excessive forms of organisational 
behaviour such as theft, violence at work, 
poor productivity, increased numbers of 
accidents, absenteeism or workplace dealing 
(see, for example, Ghodse, 2005; Godfrey 
and Parrott, 2005).  
Such constructions of drug users as 
necessarily pathological and drug use as 
necessarily excessive also stand in rather 
stark distinction to research by Howard 
Parker and colleagues (Parker, Aldridge and 
Measham, 1998; Measham, Aldridge and 
Parker, 2001; Parker, 2001; Parker et al., 
2002). Based upon extensive longitudinal 
research into young people's use of and 
attitudes to drugs, this team of researchers 
argues for an emergent normalisation of 
'sensible' recreational drug use amongst this 
sector of the British population. Here Parker 
and his team use the language at the core of 
this paper in a rather different way: rather 
than invoking a deliberate attempt to instil 
certain behaviours and attitudes in the young 
adult population, their deployment of the term 
'normalisation' refers to an organic 
development whereby drug use is becoming 
more and more normal amongst this group of 
people, with no conscious cultivation or 
intervention by external agencies involved. 
The dimensions of normalisation which they 
identify, then, include the widespread 
availability of and access to recreational 
drugs; high drug experimentation and usage 
rates compared with other European 
countries (see also Brown and McMinn, 
2004); tolerant attitudes to sensible 
recreational use by non-users (see also 
Robson, 1999); and a wider - and growing - 
accommodation of illegal drug use amongst 
the UK population per se. The tag 'sensible' in 
this research is also multi-dimensional in its 
connotations, but the important issue for our 
purposes is how it captures patterns of drug 
choice and drug consumption that are self-
managed so as not to undermine 'the 
everyday activities of studying, working, 
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seeing friends, playing sport and so on' and 
are also generally 'benign in respect of 
friendships, informal parties, romantic 
relationships, socialising and dancing' 
(Measham et al., 2001, pp. 12, 17). 
On the face of it, then, we have two 
opposing constructions of drug taking. One - 
the Parker et al. normalisation thesis - paints it 
as relatively normal and predominantly benign 
with respect to personal relationships and 
professional commitments; and this despite 
the fact that the young people studied are the 
UK's most drug-involved age group. The other 
depicts the use of any 'illicit' drug as 
dangerous and excessive, and thus 
advocates normalisation of a very different 
kind - in the shape of workplace drug testing - 
in order to address this. In order to unpack 
these conflicting representations, in this 
paper we deliberately juxtapose the concept 
of normality with that of excess. Linking drug 
taking to excess is, we would assume, 
intuitively straightforward to most readers, 
given that it involves a movement beyond 
'normal' boundaries of perception or legality. 
Nonetheless, in this paper we attempt to shed 
further light on this discursive connection as 
opposed to taking it as read - ie, why might 
we be attracted to excessive activities of this 
kind? In addition, the conjunction of 'normal' 
and drugs in the Parker et al. thesis is of 
course much more provocative. Here we 
extend this to realms beyond those 
considered by Parker et al. - ie, beyond the 
notion that young British adults are becoming 
gradually more involved with or accustomed 
to drug use in their leisure time. We analyse 
responses to the issue of drugs by 
organisations, employees and the academy 
which can likewise be described as normal, 
predictable, perhaps even functional. 
Paralleling this move, we also subject such 
responses to critical questioning by tracing 
throughout the continual presence of excess, 
as one of normality's intersecting others. 
Our specific contribution is precisely the both/ 
and (both normal and excessive) thread that 
we draw throughout the paper, as a 
corrective to the either/ or accounts produced 
in orthodox and more radical work alike on 
drug use to date. Using this approach we 
explore the following issues: 1. why drug 
taking itself is at one and the same time 
normal and excessive; 2. why organisational 
responses to employee drug use are 
understandable (and thus normal), but at the 
same time not necessarily effective or worthy 
of emulation (ie, excessive); 3. why 
employees' resistance to drug testing is to be 
expected (normal) yet might potentially 
enmesh them more deeply in this management 
technology (and is therefore excessive); and 
4. why the critical academic gaze on 
workforce drug testing is a simultaneously 
important (/ normal/ functional/ beneficial) yet 
potentially dangerous or premature (and so 
excessive) terrain to occupy. 
Normal(ising) excess 1: drug taking
It is fairly easy to make the discursive 
connection between drugs and excess. 
British argot describing the effects of the 
ingestion of drugs - being 'nutted', 'out of it', 
'mashed', 'tripping', etcetera - certainly 
illustrates the transgressive, intemperate 
nature of the high. Here though, rather than 
taking it as a given, we seek to explain the 
perennial attraction of the excess that drug 
taking represents by using Bataille's 
discussion of the abject. This requires a 
prefatory detour through his 
psychoanalytically informed analysis of the 
relationship between life and death (also see 
Brewis & Linstead, 2000; Brewis & Warren, 
2001; Warren & Brewis, 2004). 
Bataille (1991) posits that the basis for all life 
on earth is the limitless energy provided by 
the sun. This solar energy is, he suggests, 
used in three ways. Living organisms make 
use of it to subsist and to grow, but cannot 
increase in either number or size unchecked 
as there is simply insufficient room on this 
planet (Bataille, 1985, pp. 29-31). So some of 
this energy (the excess) must always be 
squandered - ie, spent without return. The 
most profound squandering of energy without 
return is death, but human beings also 
dissipate energy in activities like dancing, 
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hysteria, sex, gorging ourselves, getting 
drunk and (we would add) drug taking. 
Because of their wasteful, unproductive, 
excessive character, Bataille suggests such 
behaviours contain within them the taint of 
death, and refers to them as abject. But he 
also argues that the compulsion to waste 
energy torments us (Bataille, 1985, p. 69); 
that death and its epiphenomena have a 
'sacrilegious charm', such that we desire 
most that which will destroy us. Indeed for 
him we cannot achieve true ecstasy unless 
at least the spectre of death is also present 
(Bataille, 1985, p. 69, 1997, pp. 225-227). So 
we seek 'the feeling of dying … those 
unbearable moments when it seems to us 
that we are dying because the existence in 
us, during these interludes, exists through 
nothing but a sustaining and ruinous excess' 
(Bataille, 1997, p. 226). We see drug taking as 
one of these vertiginous, abject experiences 
in that it allows us to taste or approximate, to 
varying degrees, 'the feeling of dying', to 
approach the total abrogation of self which 
death represents. As Lupton (cited in 
Critcher, 2003, p. 59) puts it, drug taking can 
be read as the quest for `sensual embodiment 
and the visceral and emotional flights 
produced by encounters with danger' - it 
expresses `the pleasures of the ““grotesque” 
or “uncivilised” body'. 
It is at this point where we can begin to 
identify drug taking as both excessive and 
normal. It can certainly be considered 
excessive and wasteful when understood in 
terms of a narrow, instrumental, productive 
rationality, but is simultaneously normal 
because - if we work with Bataille's thesis 
regarding the inevitability of excess energy 
and the necessity of expenditure - excess 
and waste are part of the condition of all life 
on earth. Recalling Parker et al.'s 
normalisation thesis, that drug taking is 
becoming both more normal and more 
accepted amongst young British people, we 
would add to it Robson's (1999, p. 254) 
comment that there is in fact evidence of drug 
use in every human society. There seems to 
be, as Baroness Susan Greenfield also 
suggests, 'something about human nature that 
does like to abrogate [the self] from time to 
time. It's about letting go, remaining in the 
present - whether it's through drugs, sex, 
music, or dancing' (quoted in Brown and 
McMinn, 2004, p. 135). So taking drugs, we 
would suggest, is in many ways just as 
'normal' as it is 'excessive'. 
However, while the excessive character of 
drugs may be the source of their persistent 
fascination (and normalisation), we would 
certainly not deny that drugs appal as much 
as they appeal, and usually for precisely the 
same reasons. As McDermott (cited in 
Critcher, 2003, p. 60) argues, despite the 
widespread and accepted use of alcohol and 
prescription drugs like anti-depressants in 
advanced capitalist societies in the west, the 
notion 'that it is inherently wrong to seek to 
alter one's consciousness through artificial 
means' is still commonplace. Again turning to 
Bataille is instructive in examining this belief. 
As implied in our discussion above, he tells us 
that there is a '[k]ind of ambivalence between 
the most horrible and the most magnificent' 
(1985, p. 4) in the human condition; that our 
compulsion to annihilate ourselves co-exists 
(predictably enough) with a terror of death 
and all that is associated with it. The 
inevitability of death is a prospect we find at 
least as terrifying as it is seductive, because 
it reminds us that we are made up in the final 
analysis only of cells of various kinds and 
that in this we scarcely differ from other life 
forms (Bataille, 1997, p. 250). Moreover, 
although we are aware that death comes to 
us all in the end, we nevertheless labour to 
extend our lives for as long as possible to 
prove there is something unique about being 
human, something elevating us above the 
voracity and anonymity of nature. This 
manifests itself in a general emphasis on the 
future because a preoccupation 'only with the 
present', according to Bataille (1991, p. 58), is 
characteristic of animals, and we want to see 
ourselves as more than animals. We also fear 
any reminder of our eventual demise (Bataille, 
1997, p. 249).
Although at times, then, we embrace the 
excessive, the wasteful and the undisciplined 
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- including drug taking - we also deeply 
mistrust it, shying away from such 
behaviours because they involve a spending 
of energy without return and thus are 
oriented only to the present moment. So 
although the abject will always haunt us - 
because superfluous energy must somehow 
be released - we usually try to suppress it or 
to redirect its insistent drives into something 
socially 'beneficial' or 'productive' like work, 
nuclear family relationships or religious faith 
(Boulous Walker, 1998, p. 109 - pace 
Kristeva). This is because our compulsion to 
ward off death works against the drive to 
squander (for example, by taking drugs). 
Indeed Dorn and South (1987, pp. 2-3 - 
emphasis added) argue that one of the 
reasons why drugs, and heroin in particular, 
are so loathed by what we might call the 
moral majority is because 'Drug abuse 
generally, and heroin use specifically, 
signifies the very opposite of the idealised 
stereotype of masculinity. Drug users are 
often seen … as weak, vulnerable, lying, 
cheating, concerned with pleasure, turning 
away from responsibility in the world.' Here 
then, as far as drug use is concerned, we 
land back on the excessive side of our 
central couplet and its connotations of 
pathology and dysfunction.
Following Bataille, however, the denial or 
repression of the normality of temporary 
excess, as offered by the consumption of 
drugs, could itself be understood as 
excessive - and we suggest below that 
organisational responses to workforce drug 
taking may be usefully explored as just that.  
Normal(ising) excess 2: organisational 
policy
If drug use can be interpreted as a normal 
human search for excess or pro tem escape, 
then perhaps the modern citizen-employee 
has additional reasons for seeking such 
solace. As far back as 1821, De Quincey's 
Confessions of an English Opium Eater 
(cited in Plant, 1999) documented the 
consumption of opium by Manchester's 
factory and mill workers to ease the rigours 
of their working day and help them sleep at 
night. In the present day, similarly, a sizeable 
proportion of 'primarily educated, employed 
young [British] citizens with otherwise 
conforming profiles' report regularly 
consuming recreational drugs as 'de-
stressing, chilling out activity, whereby 
intoxicated weekends and going out to “get 
out of it” is the antidote to the working week' 
(Parker et al., 2002, p. 960). So one aspect of 
drug use might be workers' attempts to 'cope 
with a stressful environment that 
management has imposed; it is in this sense 
management-driven, rather than a problem 
that workers bring to the workplace' (Draper, 
1998, p. 73). Here then we are configuring 
drug taking as a direct response to the 
experience of productive labour. As further 
evidence, Hollinger's survey of 9175 
American employees, spanning forty seven 
organisations across three industries, 
suggests that these workers were more likely 
to work under the influence of drugs 'when 
they felt unhappy about their jobs' (Hollinger, 
1988, p. 439). Other relevant research by 
Bray, Fairbank and Marsden (1999) 
concludes that the consumption of drugs by 
US military personnel rises in proportion with 
their work-related stress levels. The IIDTW 
(2004, p. 71) also states that employers need 
to understand that 'an unhealthy and/ or 
excessively stressful work environment can 
contribute to substance problems'. 
Taken together, what these accounts imply is 
that the consumption of drugs is a far from 
exceptional compensation for those 
submitting to the demands of today's greedy 
organisations. Drug use to temporarily leave 
behind the confines of the organisational self 
might therefore be both understandable and 
normal. At the same time, and as we have 
argued above, drug taking simultaneously 
represents the wasteful antithesis of the 
human project to defer death, and of 
productive work as a particular element of 
this project. It should come as no surprise, 
then, that workplace drug policies - and 
testing more specifically - are being 
increasingly regarded in the UK as a justified 
(ie, normal, legitimate) response to the 
   Vol 5 Issue  5.1  2006 ISSN 1532-5555
43
'problem' of the drug-using employee. 
Nonetheless, we would like to argue that 
such interventions might themselves also be 
excessive, for a number of reasons: i) 
evidence of the deleterious effects of 
employee drug use on overall organisational 
performance is both contradictory and poor; 
ii) evidence of a demonstrable improvement in 
organisationally desirable behaviour as a 
result of drug testing is likewise insubstantial; 
and iii) workforce testing is a disproportionate 
response to employee drug use, given the 
adverse effects that such programmes also 
generate. 
On the first of these points, the data 
connecting employee drug taking with 
accidents, absence, low productivity or poor 
performance are not especially credible, as 
the IIDTW (2004) observes and we have 
suggested earlier. Though the IIDTW accepts 
drug use could be a risk factor in safety-
critical industries like transportation or mining, 
they simultaneously stipulate that even here 
accidents are more likely to be related to 
inadequate working conditions, sleep or 
health problems, high workloads and stress. 
The Inquiry also argues that inflated claims 
concerning the organisational damage caused 
by employee drug use are often made by the 
providers of drug testing technologies 
themselves. In seeking to address the 
hyperbole of such producer-led claims, Harris 
(2004) considers the available evidence. He 
notes to begin with that there has actually 
been very little new research on this topic 
since the early 1990s, as well as pointing out 
that the data are contradictory and offer 
scant evidence of a link between employee 
drug use and negative organisational 
consequences. For example, in the late 1980s 
Normand et al. found no significant 
relationship between worker drug use and 
accidents, and only an insubstantial 
connection with absenteeism and non-
voluntary turnover. Intriguingly, moreover, 
findings from Gill and Michaels and Register 
and Williams in the early 1990s reported 'a 
positive relationship between substance use 
and wages and suggested that substance 
use may relieve tension, thereby enabling 
employees to work more effectively' (Harris, 
2004, p. 310 - emphasis added). At the end of 
the same decade, Hoffmann and Larison did 
find drug users were more likely to be fired - 
but also that there was a lower rate of 
accidents amongst those who had used 
cocaine in the three years prior to their data 
collection compared to non-users. To this 
ambiguous picture, we can add recent 
research by Smith, Wadsworth, Moss and 
Simpson (2004) for the Health and Safety 
Executive into The Scale and Impact of Illegal 
Drug Use by Workers. Here 'there was no 
association between drug use and workplace 
accidents' (page 11) - the authors' conclusion 
that 'recreational drug use may reduce 
performance efficiency and safety at work' 
(page 12 - emphasis added) notwithstanding. 
We might suggest, then, that workplace drug 
testing is a solution in search of a problem - 
and can thus be considered excessive.
And if the evidence for the organisational 
problems caused by workforce drug use is 
weaker than might have been expected, then 
equally unconvincing are data indicating that 
the implementation of testing helps to resolve 
organisational or individual employees' 
difficulties. Francis et al. (2003, p. 3) argue 
that, although 
'particular research studies have 
indicated the frequency of occupational 
injury has reduced, and employee 
performance and productivity has 
increased following the implementation 
of workplace alcohol and drug testing 
... too few empirical studies on the 
effectiveness of workforce alcohol and 
drug testing exist to conclude that it 
reduces health and safety problems 
and increases employee productivity 
and performance.'  
Moreover, just as there appears to be 
insufficient evidence of a causal link between 
the introduction of testing and an upturn in the 
organisational bottom line, Wood (1998, p. 
140) cites data from both the American Civil 
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Liberties Union and 9-to-53  to  the  effect  that 
testing regimes actually often reduce 
employee performance, given the heightened 
levels of management surveillance involved 
and their demotivating consequences. Indeed 
she comments that testing increases stress, 
anxiety and general illness levels amongst 
workers. Draper (1998, p. 83) too is a harsh 
critic of the supposed benefits of workplace 
drug testing for the individual employee, 
arguing that `[m]ost drug tests diagnostically 
do nothing positive for the employee, unless 
individuals have such severe psychological 
denial that they have no idea they have taken 
drugs or become intoxicated'. So we can 
suggest this managerial intervention is unlikely 
to have beneficial motivational effects either 
for those who test positive for drugs or those 
who do not. There is also evidence - from 
Lillibridge, Cox and Cross's (2002) study of 
Australian nurses who self-identified as 
abusing drugs - that organisational treatments 
on offer to drug users might be regarded as 
punitive and stigmatising, thus further 
undermining any individual benefit to be 
derived from a positive test result.
In fact both Draper (1998) and the IIDTW 
(2004) argue that drug testing is only 
legitimate (/ normal/ beneficial) when certain 
stringent conditions are met - for example, 
provable employee impairment at work due to 
the use of drugs; circumstances where 
public trust and/ or safety are paramount - 
amongst police officers, say, or those 
involved in risky professions such as 
construction or mining; full accreditation of 
test providers' expertise; and explicit 
communication to workers as to how often 
they are able to test positive before 
disciplinary consequences like dismissal 
result. If workforce drug testing occurs 
outside of these tightly defined conditions, we 
can presumably regard it as disproportionate 
or otherwise excessive. But testing can also 
be read as excessive in other ways. 
First, it represents an extreme in the 
managerial invasion of employee materiality. 
3 A US organisation representing the interests of 
working women.
While employers also seek to control 
employee bodies via recruitment and selection 
procedures, skills training, organisational 
architecture, uniform policies and dress 
codes, weight checks and so on, drug testing 
is unique in delving beneath the body's 
surface to gaze on what lies within. The most 
common form of workplace testing is 
urinalysis, although as suggested earlier 
blood, sweat, saliva and hair tests are also 
used. As Wood (1998, p. 156) puts it, 
'Assuming that pure bodies, free of … illegal 
drugs, will be more productive and less costly 
bodies, employers literally attempt to control 
the physical substrate and internal functioning 
of worker bodies.' Here the managerial eye 
aims to see beyond visible manifestations of 
'acceptable' organisational behaviour - 
productivity rate, attendance, disciplinary 
record - to quite literally survey the chemical 
makeup of its workforce. Such a technology 
has serious implications for individual privacy 
and a number of relevant cases have been 
taken by employees to US courts on this 
basis; although these have met with limited 
success (Gilliom, 1994). The IIDTW (2004) too 
regard privacy as a central concern in this 
regard, and suggest that UK workplace drug 
policies may lead to some important test 
cases based on the Human Rights Act in the 
future. Second, and relatedly, such regimes 
have been criticised as enabling the 
organisation to take on a policing role 
conventionally understood to be the preserve 
of the state. Hecker and Kaplan (1989) and 
Gilliom (1994), for instance, argue that 
workforce drug testing should be grouped 
with CCTV on city streets, identity cards and 
the computerisation of police records; all of 
which are typically identified as intensifying 
the state's panoptic surveillance of our lives, 
and concomitantly threatening individual 
citizen-employees' liberty.
Third, testing can be said to constitute an 
excessive colonisation of employees' leisure 
activities in the name of the organisation. In an 
era where work-life balance seems to be of 
primary concern to employees, employers 
and wider society alike, it is ironic that the 
greedy organisation appears to be thriving in 
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this respect  (Warren & Wray-Bliss, 2003). 
Wood (1998, p. 147), for example, describes 
drug testing as rendering the employee 
'transparent', 'giving the employer access to 
the worker's activities, practices, and states 
of being' both inside and outside the 
organisation. Relatedly, Draper (1998, p. 66) 
argues that drug policies - and testing in 
particular - pass the buck for organisational 
problems like absence to 'vulnerable' 
employees who 'compromise' their own work 
performance because of their 'excessive' 
leisure activities; thus effectively absolving 
the organisation of any responsibility in this 
regard. In other words, organisations can 
blame an individual's poor performance of 
whatever kind on his or her drug use, as 
opposed to making a concerted effort to get 
to its root - which may well be of 
management's making (eg, work overload of 
some kind, or inadequate training). Drug 
testing can therefore be seen as normalising 
and individualising, to borrow again from 
Foucault.
Finally, there is the possibility that the labelling 
of an employee as a drug user may impact 
not only on that individual's employment, but 
on their very employability. According to the 
American Management Association, 
therefore,
'Drug testing, where utilized, ought to 
be part of a comprehensive policy on 
workplace drug abuse that includes 
education, supervisory training, and 
opportunities for counselling and 
treatment ... Testing cannot and 
should not take the place of good 
supervision and management 
practices.' (cited in Draper, 1998, pp. 
96, n4, 99, n17 - emphasis added) 
The IIDTW (2004, p. 62) concurs, stating that 
'For the majority of businesses, investment in 
management training and systems is likely to 
have more impact on safety, performance 
and productivity than the introduction of drug 
testing at work.' 
To recap, we have suggested that, although 
there appears to be a momentum building for 
the normalisation of workforce drug testing in 
the UK, such interventions may be 
simultaneously identified as excessive. 
Evidence to justify their imposition and their 
efficacy is poor, and testing also generates a 
range of effects which could well outweigh 
whatever organisational risks exist. Within the 
conventions of the field of CMS, the usual 
tendency upon identifying a potentially 
excessive managerial intervention of this kind 
would be to explore employee resistance as 
a potentially legitimate counter-response 
(Wray-Bliss, 2002) - and we do indeed turn to 
employees' resistance to drug testing next. 
However, and in keeping with the both/ and 
motif of our central argument, we also 
consider whether some of the emerging and 
potential forms of resistance to this 
managerial technology may themselves be 
explored as excessive. 
Normal(ising) excess 3: employees' 
responses
Perhaps unsurprisingly, most academic 
management literature emphasises the 
managerial prerogative and represents 
workforce resistance to management 
interventions as unjustified or excessive. 
CMS writing, on the other hand, typically 
takes the opposite stance (Fournier and Grey, 
2000). So, where mainstream work identifies 
managerial control as a normative 'good' - for 
example, the unitarist privileging of strong 
corporate cultures by Peters and Waterman 
(1982) and Deal and Kennedy (1988) - CMS 
has explored employee resistance as a 
predictable, indeed normal, response to the 
morally dubious nature of this control (see, 
for instance, on the subject of cultural 
engineering, Kunda, 1992, and Aktouf, 1996). 
As self-identified CMS academics, we agree 
with this depiction of workforce resistance. In 
fact one of us has argued elsewhere that 
much CMS scholarship doesn't go far enough 
in naming or exploring the purposes, 
meanings and effects of workforce 
resistance (Wray-Bliss, 2001, 2002; also see 
Prasad and Prasad, 2000). Furthermore, and 
as with any managerial technology, there are 
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a range of resistant practices available to 
employees as responses to drug testing. 
Union representation, 'drug holidays' (ie, 
abstaining for a specific period) to clear one's 
system in time and deliberately missing a test, 
for example, have each been identified in 
existing literature - but hitherto insufficiently 
explored. As we have suggested above, 
given that organisational drug policies can in 
many ways be understood as excessive, 
such responses may also be identified as 
predictable and normal, even functional. 
Nonetheless, and in the spirit of this paper's 
interrogation of the intersections between the 
'normal' and the 'excessive', we now reflect 
on whether some of the potential forms of 
workforce resistance to testing could 
simultaneously be identified as excessive. 
First, there is evidence to suggest that, with 
the introduction of more rigorous drug testing 
in British prisons, inmates have begun to 
switch from using cannabis - a soft drug that 
can remain detectable in the body for up to 
thirty days - to harder and potentially more 
harmful drugs like heroin which leave the 
system in far less time (Edgar and O'Donnell, 
n.d.). This attempt to evade the 
consequences of a positive drug test poses a 
much more serious problem both for the 
inmates themselves and for the prison 
authorities, reinforcing Draper's (1998, p. 85) 
point that the 'subterfuge' entailed to beat a 
test actually 'intensifies managerial problems'. 
In addition to efforts to minimise the time 
window in which drug users are vulnerable 
to a test, there are ways in which they can 
fool the technology itself. Professional 
athletes, to take the most visible example, 
have been known to go to what may be seen 
as excessive lengths in this regard. Indeed 
methods to mask a competitor's use of drugs 
seem to have evolved alongside the 
development of testing procedures 
themselves. Former physiotherapist for the 
Festina Tour de France cycling team Willy 
Voet, for instance, discusses the transition 
from the use of a bulb of clean urine hidden 
under the arm, connected to a tube under the 
clothes and utilised when cyclists were 
allowed to give samples fully clothed, to the 
rather more extreme method of injecting clean 
urine up the urethra prior to a test once the 
procedures became more meticulous (Voet, 
2001, p. 47).
It is not just in the sporting realm, however, 
that individuals might utilise such tactics, and 
numerous internet sites offering advice and 
products in this regard already exist. Pass 
any drug test (n.d.), PassYourDrugTest.com 
(n.d.) and How to pass your drug test (n.d.) all 
offer anything from drinks to clear your urine 
of toxins through shampoo to detox your hair 
to home testing kits and advice on how to 
explain away a positive test to employers. 
Indeed, the compilers of How to pass your 
drug test present as a medical laboratory 
researching in this field and provide contact 
details of trained operatives able to answer 
any questions one might have. Similarly, 
PassYourDrugTest.com advertises products 
to purge the urine, blood and hair for the 
discerning 'moderate', 'heavy' or 'extreme' 
user, including '1 hour emergency tea' which 
enables preparation even for random testing. 
This site also provides information about the 
companies that test, how they test and 
common questions that are asked prior to 
testing. 
As we have suggested, these responses 
may be seen as normal or legitimate, 
reproducing as they do the organisational 
cycle of management control and employee 
resistance with which we are already familiar 
from existing CMS research. Thus a new 
technology of control is developed and a 
counter-technology and knowledge base 
quickly emerges to resist it. Why then do we 
suggest that this resistance might also be 
excessive? Our argument here turns on the 
fact that these strategies imply a level of 
forward planning, a commitment to get high, a 
seriousness of intent that seems to shift the 
nature of drug taking itself away from 
vertiginous, wasteful, non-productive 
escapism. Someone pursuing these 
strategies instead seems to become more 
deeply enmeshed in the concerns of 
management power, in the practices of 
technology and the science of testing. The 
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temporary abrogation of the productive self 
that recreational drugs offer, we suggest, 
risks being attenuated - if not rendered 
entirely inaccessible - by the heightening of a 
self-surveilling, test-focused subjectivity. And 
while such strategies may be understandable 
given the pressures to perform and threat to 
reputation and remuneration that prevail in the 
professional sporting arena, we may ask 
whether for the vast majority of the working 
population their active pursuit can be easily 
reconciled with Parker et al.'s definition of 
sensible recreational drug use.                     
Conclusion: excessive academic 
interest?
We began this paper by summarising the 
normalisation thesis that Parker and his 
colleagues have been constructing around 
recreational drug use amongst the UK's 
young adult population. This work has 
undertaken the intellectually and morally 
challenging task of linking drug taking with 
normality as well as excess. We have sought 
to build upon it by both i) extending the trope 
of normality into other - especially 
organisational - realms to examine drug use, 
organisational responses to drug use and 
employees' responses to organisational drug 
policies and ii) simultaneously questioning the 
normality of responses to drugs in this arena 
by reference to one of normality's others - 
excess. Our intention has been to 
problematise the dualistic, either/ or 
constructions which pervade existing 
analysis, so as to begin to provide an account 
of workforce drug testing that engages with 
some of the considerable ambiguities and 
complexities inherent in this topic. 
We wish to conclude by justifying but at the 
same time problematising our own reaction to 
organisational drug policies. Might this also be 
labelled excessive? First, we consider 
whether we protest too much when testing in 
particular is scarcely a widespread 
phenomenon in the UK. Second, we ask 
whether our critique might contribute to 
constructing drug use as a 'problem', thereby 
inadvertently raising the profile of testing and 
contributing to its organisational uptake. Third, 
we reflect on whether, by taking an explicitly 
critical stance on the issue of workforce drug 
testing, we may be read as uncritically 
endorsing drug use. 
The first critique of our potentially excessive 
interest in drug use can be broken down into 
'numerical' and 'moral' components. The 
numerical critique reminds us that workforce 
drug testing in the UK is still not commonplace 
and, where it does exist, it may be 
predominantly on a for cause basis, when 
suspicions of problematic drug use affecting 
employee performance have already been 
aroused. Thus drug testing could be seen as 
a marginal issue that does not warrant our 
critical academic gaze. In response we of 
course accept that testing currently affects 
only a small percentage of British employees. 
However we might also ask how many it 
needs to affect before it becomes a legitimate 
topic of scholarly enquiry, particularly given 
the evidence of increasing momentum for 
testing in the UK. We might further suggest 
that organisational testing, given the invasion 
of privacy, extension of managerial 
prerogative and shoring up of broader 
surveillance regimes that it represents, has a 
potential impact on wider UK society - not just 
on those who are tested or who use drugs. 
Finally, we suggest that for CMS academics it 
might be strategically more beneficial to 
interrogate a managerial technology of control 
before it is firmly established. The moral 
critique of our 'excessive' interest in the 
'minority' issue of workforce drug testing can 
be phrased as a challenge to the idea that the 
rights of drug users are a legitimate area for 
academic concern. We, however, do not 
subscribe to this particular  understanding. 
Specifically, we do not feel that, by virtue of 
the choice to consume recreational drugs, 
individuals are thereby disqualified from our 
moral/ political concern regarding the 
potentially serious effects of this managerial 
intervention upon their employment or indeed 
their actual employability. 
The second critique of the possibly excessive 
nature of critical academic interest in drug 
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testing may be summarised as the question of 
whether engagement with this topic risks 
reinforcing constructions of the 'problematic' 
drug-taking employee. These inscriptions may 
be argued to relocate such activity from 
'private' space into the 'public' domain. Such a 
process, for us, resembles Foucault's (1991) 
depiction of the discursive appearance of the 
category of sexuality in the west during the 
eighteenth and nineteenth centuries. Contrary 
to what he refers to as the repressive 
hypothesis (the idea that we westerners 
have gradually come to refuse to speak about 
any non-heterosexual, non-conjugal, non-
procreative form of sex), Foucault suggests 
that what has taken place instead is a 
proliferation of discourses 
'concerning sex in the field of exercise 
of power itself: an institutional 
incitement to speak about it, and to do 
so more and more; a determination on 
the part of the agencies of power to 
hear it spoken about, and to cause it to 
speak through explicit articulation and 
endlessly accumulated detail … sex 
was taken charge of, tracked down as 
it were, by a discourse that aimed to 
allow it no obscurity, no respite.' 
(Foucault, 1991, pp. 302-303)
In areas from pedagogy to political criticism, 
westerners were thus alerted to the ever-
present perils of sex, the need for 
conscientious monitoring of sexual behaviour 
and the importance of diagnosing, treating 
and where necessary punishing sexual 
'perversions'. This heightened attentiveness 
Foucault (1991, p. 314) describes as an 
'immense verbosity' around sex, which 
created new categories of 'dangerous' 
sexual subjects - such as the homosexual 
man. We contend that a similar process may 
be at work in the emergence of the discursive 
category of the 'dangerous' drug-taking 
employee. The history of the last two 
centuries in the west shows that alcohol and 
drug use have conventionally been 
understood by the state as an abuse of 
reason, signalling idleness, vice or a lack of 
moral fibre on the part of the consumer 
(O'Malley and Valverde, 2004). However, 
attention to drugs in the context of work - as 
an organisational problem requiring 
management intervention - emerged in the US 
some time during the 1960s, and developed 
apace following the passing of the Drug-Free 
Workplace Act in 1988 (Draper, 1998). So the 
intersection of drugs and work came under 
renewed public scrutiny from the late 1980s 
onwards. 
In Foucauldian terms, then, we could argue 
that this has generated a growing 'incitement 
to speak about' drug use by employees, and 
'to do so more and more', 'a determination on 
the part of the agencies of power [corporate 
shareholders and senior managers] to hear it 
spoken about' and 'to cause it to speak 
through explicit articulation and endlessly 
accumulated detail' - asking employees to 
self-disclose as drug-users and/ or 
subjecting them to tests revealing them as 
such. Indeed the 'specification' and 
'solidification' (Foucault, 1991, p. 323) of the 
aberrant category of the drug-taking 
employee might be said to be all but complete 
in the US, and under way on the other side of 
the Atlantic. So by commenting on this 
specification and solidification, even in a 
critical way, might we not be adding to this 
managerialist power-knowledge regime? Are 
we at risk of extending the 'lines of 
penetration' (Foucault, 1991, p. 322) of the 
employee's body by turning our own critical 
gaze upon it?  Our interventions in these 
debates are not outside of the managerialist 
discourse on drugs but are rather part of its 
'limit … [its] underside … [a] counter-stroke, 
that which responds to every advance of 
power by a movement of disengagement' 
(Foucault, 1980, p. 138) - which also implies 
that such resistance can be co-opted by the 
discourse it speaks against. So our 
suggestion that workforce drug testing is 
potentially excessive and counter-productive 
perhaps risks, in its turn, being assimilated by 
managerialist rhetoric as further evidence of 
the need to tackle the problem of employee 
drug taking. This is perhaps especially likely 
when CMS academics try to engage in 
dialogue with managers who may well (and 
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with some justification) regard them as having 
emerged temporarily from the ivory tower to 
rail about subjects they do not fully 
understand. Might we be better advised to 
adopt a strategic silence on this topic as a 
more effective critical strategy?  By 
participating do we risk further inscribing 
employee drug use as an important area for 
investigation - and therefore managerial 
action?
Our final reflection on the potentially 
excessive interest of critical academics in the 
area of organisational drug policies focuses 
upon the issue of harm. By taking a critical 
stance on the issue of testing we could of 
course be criticised for neglecting the 
dangers of drug use, if not glorifying drugs 
per se. Certainly we have concentrated here 
on critiquing responses to drug use rather 
than critiquing drugs or drug users. However, 
we do not wish to give the impression that 
we regard drugs as safe. After all, if drug 
taking can be regarded as abject and 
excessive, then it necessarily carries with it 
what we referred to earlier as the taint of 
death. Robson (1999) usefully summarises 
some of the attendant problematics and their 
variants, including the ingestion of dangerous 
adulterants introduced into the drug at some 
point during its production, negative effects 
on 'energy, concentration, mood, or physical 
health' (page 20) and the mortality rates 
associated with poly drug use in particular 
(pages 27-28). 
In short, drugs are dangerous. Even if we 
accept the Parker et al. characterisation of 
many drug users in the UK as 'sensible', this 
characterisation still implies the continual, 
inescapable presence of risk - risk that drug 
users need to be sensible about. However, 
we would also argue that the undeniable 
presence of risk should not manoeuvre us 
into a position of silence regarding the 
possible excesses of managerial 
interventions into both the behaviour and 
biology of employees. 
To close, we wish to reiterate our key 
contribution. The dualistic, either-excessive-
or-normal tenor of existing analysis - drugs 
and drug users as bad versus drugs in 
themselves as not essentially problematic and 
drug users as capable of 'sensible' 
consumption choices - is for us rather too 
simplistic. The both/ and approach of our 
argumentation is, we suggest, more helpful in 
appreciating why we consume drugs; why 
organisational responses to this are 
predictable but usually disproportionate; why 
employees' resistance to drug testing, while 
understandable, might actually undermine the 
intemperate high that drug taking generates; 
and why our critical academic interest in drug 
testing is justified but at the same time fraught 
with potential excesses, overstatements and 
potential for managerialist co-optation.
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